+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Family Planning Market by Contraceptive Method, Distribution Channel, Sales Type, Age Group - Global Forecast to 2030- Product Image
Family Planning Market by Contraceptive Method, Distribution Channel, Sales Type, Age Group - Global Forecast to 2030- Product Image
Sale

Family Planning Market by Contraceptive Method, Distribution Channel, Sales Type, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924830
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Family Planning Market grew from USD 62.82 billion in 2024 to USD 67.23 billion in 2025. It is expected to continue growing at a CAGR of 6.68%, reaching USD 92.64 billion by 2030.

Setting the Stage for Family Planning Excellence

Family planning stands at the heart of public health and social equity, empowering individuals and communities to shape their futures with confidence and control. Recent advances in medical technology, shifts in societal attitudes, and evolving healthcare policies have converged to redefine how contraceptive solutions are developed, distributed, and adopted across the United States. As demographic trends highlight the need for tailored reproductive health options, decision-makers must navigate an increasingly complex environment where access, efficacy, and affordability intersect.

This executive summary synthesizes the most pressing developments shaping the family planning sector. It provides a roadmap for exploring emergent trends, analyzes the ramifications of tariff adjustments set to take effect in 2025, and distills key segmentation insights across contraceptive methods, distribution channels, sales types, and age cohorts. By examining regional variations and highlighting leading industry players, this overview offers a cohesive foundation for stakeholders aiming to anticipate market shifts and craft informed strategies.

Navigating the Transformative Shifts Reshaping Contraceptive Access

The past decade has ushered in a wave of transformative shifts reshaping contraceptive access and innovation. Rapid integration of digital health platforms and telemedicine services has dramatically broadened the channels through which individuals engage with healthcare providers, accelerating adoption of personalized family planning regimens. Advances in product design, from extended-release implants to user-friendly vaginal rings, underscore a movement toward more discreet, long-lasting options that align with diverse lifestyle needs.

Concurrently, policy reforms at federal and state levels have recalibrated insurance coverage requirements and reimbursement protocols, directly influencing affordability and provider incentives. The rise of value-based care models encourages a focus on preventive health, elevating family planning as a cornerstone of holistic wellness strategies. Societal attitudes are also evolving, with growing emphasis on inclusive education and male engagement in reproductive responsibility. Together, these forces are redefining market expectations and creating opportunities for innovators to deliver differentiated solutions.

Unpacking the Cumulative Impact of 2025 United States Tariffs

The introduction of revised tariffs on contraceptive devices and raw materials in 2025 marks a pivotal turning point for manufacturers, distributors, and end-users. Increased duties on imported polymers, metals, and active pharmaceutical ingredients have elevated production costs, prompting supply chain realignments and a reassessment of domestic sourcing strategies. As manufacturers absorb or pass through these cost pressures, product pricing and reimbursement landscapes are poised to adjust, with direct implications for both over-the-counter and prescription markets.

Stakeholders must evaluate the cascading effects of these tariff adjustments, which may include tighter margins for multinational corporations and heightened incentives for local production. Healthcare providers could experience shifts in procurement patterns, while payers may renegotiate formularies to balance clinical efficacy against budgetary constraints. Ultimately, these cumulative impacts underscore the need for agile supply chain management and proactive policy engagement to safeguard equitable access and sustain market growth.

Deep Dive into Market Segmentation Driving Contraceptive Choices

Market dynamics in family planning hinge on a nuanced understanding of consumer preferences and product attributes. When evaluating contraceptive methods, the landscape spans barrier solutions, hormonal therapies, intrauterine devices, natural approaches, and sterilization. Barrier methods encompass devices such as diaphragms, female and male condoms, and spermicides, while hormonal options range from implants and injections to oral contraceptives, patches, and vaginal rings. Intrauterine systems divide into copper IUDs and hormonal IUS formats, and natural strategies include rhythm methods and withdrawal. Permanent sterilization options cover both female and male procedures.

Distribution channels shape how these products reach end users, delivering via e-commerce, hospital pharmacies, and retail pharmacies. Sales type differentiations further delineate the market, with over-the-counter offerings like condoms, emergency contraception, and spermicides contrasted against prescription categories such as implants, injectables, IUDs, and oral pills. Age group segmentation illuminates usage patterns across cohorts aged 15-19, 20-24, 25-29, 30-34, and 35-49, revealing distinct preferences driven by life stage, risk tolerance, and healthcare engagement. This multidimensional segmentation framework provides a strategic lens through which to anticipate demand shifts and tailor product development, positioning, and outreach strategies.

Regional Dynamics Shaping the Global Family Planning Landscape

Regional dynamics play a critical role in shaping access, uptake, and growth trajectories for family planning products. In the Americas, well-established healthcare infrastructures, coupled with comprehensive insurance frameworks in key markets, support robust adoption of both innovative and traditional contraceptive methods. Urban centers drive high volume sales, while rural and underserved communities benefit from targeted outreach programs and mobile health initiatives.

Across Europe, the Middle East, and Africa, diverse regulatory regimes and cultural norms influence product availability and education efforts. In Western Europe, harmonized standards and generous public funding foster wide access to long-acting reversible contraceptives. In contrast, parts of the Middle East face unique sociocultural barriers that require culturally sensitive engagement models. Meanwhile, sub-Saharan Africa is witnessing philanthropic and governmental collaborations aimed at expanding basic contraceptive coverage and strengthening supply chains.

The Asia-Pacific region presents a heterogeneous landscape where rapidly growing economies invest in domestic manufacturing capabilities and digital distribution channels. Markets such as China, India, and Southeast Asia are experiencing increased demand for discreet, cost-effective solutions, driving innovation in compact implants and user-friendly IUDs. Cross-border e-commerce platforms are emerging as vital conduits for reaching remote populations, bridging gaps in traditional pharmacy networks.

Profiling Leading Innovators and Market Powerhouses

Leading companies are steering innovation and market expansion through targeted investments, strategic partnerships, and diversified portfolios. Global pharmaceutical giants are leveraging extensive R&D capabilities to advance next-generation hormonal therapies and novel delivery systems. At the same time, specialized device manufacturers focus on refining intrauterine technologies and enhancing the barrier method portfolio with advanced materials and ergonomic designs.

Collaborative ventures between industry incumbents and emerging biotech firms are catalyzing breakthroughs in personalized contraception, using data analytics and molecular science to tailor solutions to individual risk profiles. Distribution alliances between major healthcare providers and digital health startups are streamlining patient journeys, from teleconsultation to home delivery. Meanwhile, manufacturers are forging alliances with contract development and manufacturing organizations to optimize production efficiency and respond swiftly to regulatory shifts. These collective efforts underscore a competitive landscape defined by innovation, agility, and customer centricity.

Actionable Strategies to Lead in Family Planning Markets

To capitalize on evolving market opportunities, industry leaders should prioritize several strategic imperatives. First, diversifying product portfolios across contraceptive methods will mitigate risk and address varying consumer needs, ensuring offerings resonate with different age cohorts and cultural contexts. Second, embracing digital distribution models and telehealth partnerships will accelerate reach, especially among digitally native consumers and remote communities.

Third, proactive engagement with policymakers and payers can influence beneficial reimbursement structures and navigate tariff challenges, safeguarding margin stability and patient access. Fourth, investing in localized manufacturing capabilities will reduce supply chain vulnerabilities exposed by regulatory changes and ensure rapid response to demand surges. Fifth, leveraging real-world evidence and advanced analytics will guide targeted marketing campaigns and inform product development pipelines. Finally, forging cross-sector collaborations-between public health agencies, nonprofit organizations, and private entities-will strengthen community outreach and education efforts, reinforcing the role of family planning as a cornerstone of preventive healthcare.

Robust Research Methodology Ensuring Data Integrity

This analysis employs a rigorous mixed-methods approach to ensure depth and reliability. Primary research included in-depth interviews with healthcare providers, procurement specialists, and policy experts across multiple regions. These qualitative insights were complemented by a comprehensive review of secondary data sources, including regulatory filings, academic publications, corporate financial reports, and tariff schedules. Segmentation analysis was conducted using consumer survey data and sales performance metrics to identify patterns across contraceptive methods, distribution channels, sales types, and age cohorts.

Data integrity was ensured through triangulation of multiple sources and validation by an expert advisory panel. Advanced statistical techniques were applied to assess the significance of observed trends and to isolate the impact of external factors such as policy shifts and tariff changes. Continuous peer review and methodological transparency underpin the findings, providing stakeholders with a robust foundation for strategic decision-making.

Synthesizing Insights to Chart Future Directions

The family planning sector stands at an inflection point, shaped by technological innovations, policy developments, and shifting societal expectations. Comprehensive segmentation analysis has revealed nuanced demand patterns across contraceptive methods, distribution channels, and demographic cohorts. Regional insights highlight the importance of tailored strategies to navigate disparate regulatory landscapes and cultural contexts. Meanwhile, leading companies are distinguishing themselves through innovation, strategic partnerships, and operational agility.

As stakeholders chart a path forward, integrating these insights into cohesive strategies will be essential for driving sustainable growth and enhancing patient outcomes. By addressing tariff pressures, embracing digital transformation, and reinforcing collaborative networks, industry participants can not only adapt to evolving market dynamics but also lead the charge in expanding access to quality family planning options. The time to act is now, and informed, decisive leadership will determine who thrives in the next chapter of this critical healthcare domain.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Contraceptive Method
    • Barrier
      • Diaphragm
      • Female Condom
      • Male Condom
      • Spermicides
    • Hormonal
      • Implants
      • Injections
      • Oral Contraceptives
      • Patches
      • Vaginal Rings
    • Intrauterine Device
      • Copper Iud
      • Hormonal Ius
    • Natural
      • Rhythm Method
      • Withdrawal
    • Sterilization
      • Female Sterilization
      • Male Sterilization
  • Distribution Channel
    • E-Commerce
    • Hospital Pharmacies
    • Retail Pharmacies
  • Sales Type
    • Otc
      • Condoms
      • Emergency Contraception
      • Spermicides
    • Prescription
      • Implants
      • Injectables
      • Iuds
      • Oral Pills
  • Age Group
    • 15-19
    • 20-24
    • 25-29
    • 30-34
    • 35-49
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • CooperCompanies, Inc.
  • Organon & Co.
  • Reckitt Benckiser Group plc
  • Church & Dwight Co., Inc.
  • Ansell Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Family Planning Market, by Contraceptive Method
8.1. Introduction
8.2. Barrier
8.2.1. Diaphragm
8.2.2. Female Condom
8.2.3. Male Condom
8.2.4. Spermicides
8.3. Hormonal
8.3.1. Implants
8.3.2. Injections
8.3.3. Oral Contraceptives
8.3.4. Patches
8.3.5. Vaginal Rings
8.4. Intrauterine Device
8.4.1. Copper Iud
8.4.2. Hormonal Ius
8.5. Natural
8.5.1. Rhythm Method
8.5.2. Withdrawal
8.6. Sterilization
8.6.1. Female Sterilization
8.6.2. Male Sterilization
9. Family Planning Market, by Distribution Channel
9.1. Introduction
9.2. E-Commerce
9.3. Hospital Pharmacies
9.4. Retail Pharmacies
10. Family Planning Market, by Sales Type
10.1. Introduction
10.2. Otc
10.2.1. Condoms
10.2.2. Emergency Contraception
10.2.3. Spermicides
10.3. Prescription
10.3.1. Implants
10.3.2. Injectables
10.3.3. Iuds
10.3.4. Oral Pills
11. Family Planning Market, by Age Group
11.1. Introduction
11.2. 15-19
11.3. 20-24
11.4. 25-29
11.5. 30-34
11.6. 35-49
12. Americas Family Planning Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Family Planning Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Family Planning Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Merck & Co., Inc.
15.3.3. Pfizer Inc.
15.3.4. Johnson & Johnson
15.3.5. Teva Pharmaceutical Industries Ltd.
15.3.6. CooperCompanies, Inc.
15.3.7. Organon & Co.
15.3.8. Reckitt Benckiser Group plc
15.3.9. Church & Dwight Co., Inc.
15.3.10. Ansell Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FAMILY PLANNING MARKET MULTI-CURRENCY
FIGURE 2. FAMILY PLANNING MARKET MULTI-LANGUAGE
FIGURE 3. FAMILY PLANNING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FAMILY PLANNING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FAMILY PLANNING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FAMILY PLANNING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FAMILY PLANNING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FAMILY PLANNING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FAMILY PLANNING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FAMILY PLANNING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FAMILY PLANNING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FAMILY PLANNING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FAMILY PLANNING MARKET SIZE, BY BARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FAMILY PLANNING MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FAMILY PLANNING MARKET SIZE, BY FEMALE CONDOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FAMILY PLANNING MARKET SIZE, BY MALE CONDOM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FAMILY PLANNING MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FAMILY PLANNING MARKET SIZE, BY HORMONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FAMILY PLANNING MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FAMILY PLANNING MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FAMILY PLANNING MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FAMILY PLANNING MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FAMILY PLANNING MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FAMILY PLANNING MARKET SIZE, BY COPPER IUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FAMILY PLANNING MARKET SIZE, BY HORMONAL IUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FAMILY PLANNING MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FAMILY PLANNING MARKET SIZE, BY RHYTHM METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FAMILY PLANNING MARKET SIZE, BY WITHDRAWAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FAMILY PLANNING MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FAMILY PLANNING MARKET SIZE, BY FEMALE STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FAMILY PLANNING MARKET SIZE, BY MALE STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FAMILY PLANNING MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FAMILY PLANNING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FAMILY PLANNING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FAMILY PLANNING MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FAMILY PLANNING MARKET SIZE, BY CONDOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FAMILY PLANNING MARKET SIZE, BY EMERGENCY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FAMILY PLANNING MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL FAMILY PLANNING MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL FAMILY PLANNING MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL FAMILY PLANNING MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL FAMILY PLANNING MARKET SIZE, BY ORAL PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL FAMILY PLANNING MARKET SIZE, BY 15-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL FAMILY PLANNING MARKET SIZE, BY 20-24, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL FAMILY PLANNING MARKET SIZE, BY 25-29, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL FAMILY PLANNING MARKET SIZE, BY 30-34, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL FAMILY PLANNING MARKET SIZE, BY 35-49, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES FAMILY PLANNING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 79. CANADA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 80. CANADA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 81. CANADA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 82. CANADA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 83. CANADA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. CANADA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 87. CANADA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 88. CANADA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. MEXICO FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 90. MEXICO FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 92. MEXICO FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 98. MEXICO FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA FAMILY PLANNING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. GERMANY FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 146. GERMANY FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 154. GERMANY FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. FRANCE FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 157. FRANCE FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 158. FRANCE FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 159. FRANCE FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 161. FRANCE FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 162. FRANCE FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. FRANCE FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 165. FRANCE FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. ITALY FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 179. ITALY FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 180. ITALY FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 181. ITALY FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 182. ITALY FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 183. ITALY FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. ITALY FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 186. ITALY FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 187. ITALY FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 188. ITALY FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. SPAIN FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 190. SPAIN FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 191. SPAIN FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 192. SPAIN FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 193. SPAIN FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 194. SPAIN FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 195. SPAIN FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SPAIN FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 198. SPAIN FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 199. SPAIN FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 233. DENMARK FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 234. DENMARK FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 236. DENMARK FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 237. DENMARK FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 238. DENMARK FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 239. DENMARK FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. DENMARK FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 241. DENMARK FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 242. DENMARK FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 243. DENMARK FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 255. QATAR FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 256. QATAR FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 257. QATAR FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 258. QATAR FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 259. QATAR FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 260. QATAR FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. QATAR FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 263. QATAR FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 264. QATAR FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 265. QATAR FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. FINLAND FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 267. FINLAND FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 268. FINLAND FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 269. FINLAND FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 271. FINLAND FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 272. FINLAND FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. FINLAND FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 275. FINLAND FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 276. FINLAND FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 299. EGYPT FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 300. EGYPT FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 301. EGYPT FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 302. EGYPT FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 303. EGYPT FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 304. EGYPT FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 305. EGYPT FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. EGYPT FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 307. EGYPT FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 308. EGYPT FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 309. EGYPT FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. TURKEY FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 311. TURKEY FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 312. TURKEY FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 313. TURKEY FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 314. TURKEY FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 315. TURKEY FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 316. TURKEY FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. TURKEY FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 318. TURKEY FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 319. TURKEY FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 320. TURKEY FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 332. NORWAY FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 333. NORWAY FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 334. NORWAY FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 335. NORWAY FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 336. NORWAY FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 337. NORWAY FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 338. NORWAY FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. NORWAY FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 340. NORWAY FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 341. NORWAY FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 342. NORWAY FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 343. POLAND FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 344. POLAND FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 345. POLAND FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 346. POLAND FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 347. POLAND FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 348. POLAND FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 349. POLAND FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. POLAND FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 351. POLAND FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLION)
TABLE 352. POLAND FAMILY PLANNING MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 353. POLAND FAMILY PLANNING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 354. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY CONTRACEPTIVE METHOD, 2018-2030 (USD MILLION)
TABLE 355. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY BARRIER, 2018-2030 (USD MILLION)
TABLE 356. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 357. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY INTRAUTERINE DEVICE, 2018-2030 (USD MILLION)
TABLE 358. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 359. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
TABLE 360. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY SALES TYPE, 2018-2030 (USD MILLION)
TABLE 362. SWITZERLAND FAMILY PLANNING MARKET SIZE, BY OTC, 2018-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Family Planning market report include:
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • CooperCompanies, Inc.
  • Organon & Co.
  • Reckitt Benckiser Group plc
  • Church & Dwight Co., Inc.
  • Ansell Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 67.23 Billion
Forecasted Market Value ( USD ) by 2030 $ 92.64 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Drug Eluting Devices Market by Product Type, Technology, End User, Distribution Channel, Demographics - Global Forecast to 2030 - Product Image

Contraceptive Drug Eluting Devices Market by Product Type, Technology, End User, Distribution Channel, Demographics - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Female Contraceptive Market by Product Type, Mechanism, Distribution Channel, Generation, End User Age, Price Range - Global Forecast to 2030 - Product Image

Female Contraceptive Market by Product Type, Mechanism, Distribution Channel, Generation, End User Age, Price Range - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From

About the Family Planning Market

The Family Planning market is an important part of Women's Health, providing access to contraception and other reproductive health services. It is a diverse market, with a range of products and services available to meet the needs of women of all ages. These include hormonal contraceptives, such as the pill and the patch, as well as long-acting reversible contraceptives, such as intrauterine devices and implants. Other services include counseling, education, and access to emergency contraception. Family Planning services are essential for women to make informed decisions about their reproductive health, and to ensure that they have access to the resources they need to make those decisions. It is also important for reducing unintended pregnancies and promoting healthy pregnancies. Some companies in the Family Planning market include Bayer, Merck, Pfizer, and Allergan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.